Serving Australia and NZ
1300 543 373
Return to Previous Page

MPLA-SM, VacciGrade™, 1 mg

MPLA-SM, VacciGrade™, 1 mg

Quick Overview:

Product Code: vac-mpla
Supplier: InvivoGen

  • Details

    Monophosphoryl Lipid A from Salmonella minnesota R595 - TLR4-based adjuvant The TLR4 agonist, MPLA (monophosphoryl lipid A) is a derivative of lipid A from Salmonella minnesota R595 lipopolysaccharide (LPS or endotoxin). MPLA is considerably less toxic than LPS whilst maintaining the immunostimulatory activity. When tested in animal models as a vaccine adjuvant, MPLA induces a strong Th1 response. MPLA-SM VacciGrade™ is suitable for preclinical studies. It is prepared under strict aseptic conditions. It is guaranteed sterile.
  • Additional Information

    Supplier name InvivoGen
    Product Type Reagents
    Size 1 mg,1 mg
    Publications Publication List
    Datasheet URL View Datasheet
    Categories Reagents,Vaccine Adjuvants & Reagents,COVID-19 Products
  • Images